Literature DB >> 3011583

Healing of benign gastric ulcer with low-dose antacids and fiber diet.

A Rydning, R Weberg, O Lange, A Berstad.   

Abstract

A randomized, double-blind, placebo-controlled trial was conducted to determine the efficacy of a low-dose aluminum-magnesium antacid regimen (Link one tablet q.i.d.) (total neutralizing capacity 120 mmol HCl/day) in combination with a high- or a low-fiber diet in ulcer healing and relief of symptoms in patients with benign gastric ulcer. After 6 wk, the ulcer healed in 28 (67%) of the 42 patients treated with antacids compared with 11 (25%) of the 44 patients treated with placebo (p less than 0.001). Antacids were also significantly more effective than placebo in the relief of symptoms. The dietary treatment did not significantly influence ulcer healing or ulcer symptoms. Constipation was more frequently seen with the low- than with the high-fiber diet (p less than 0.01). No significant side effects from antacids were recorded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011583     DOI: 10.1016/0016-5085(86)90438-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

2.  Healing of chronic gastroduodenal ulcerations by antacids. Role of prostaglandins and epidermal growth factor.

Authors:  S J Konturek; T Brzozowski; D Drozdowicz; A Dembinski; C Nauert
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 3.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 4.  Antacids and ulcer healing. A review of the evidence.

Authors:  R P Walt; M J Langman
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

5.  Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteers.

Authors:  R Weberg; A Berstad; M Osnes
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

6.  Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.

Authors:  M A Hull; D J Cullen; N Hudson; C J Hawkey
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

7.  Gastric emptying of two radiolabelled antacids with simultaneous monitoring of gastric pH.

Authors:  J Monés; I Carrio; S Sainz; L Berná; P Clavé; M Liszkay; M Roca; F Vilardell
Journal:  Eur J Nucl Med       Date:  1995-10

8.  Very-low dose antacid in treatment of duodenal ulcer. Comparison with cimetidine.

Authors:  S Zaterka; F Cordeiro; L G Lyra; M M Toletino; S J Miszputen; J L Jorge; E P Silva; F E Vieira; J L Modena; H K Massuda
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

9.  Gastric adenocarcinoma masquerading endoscopically as benign gastric ulcer. A five-year experience.

Authors:  I Podolsky; P R Storms; C T Richardson; W L Peterson; J S Fordtran
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

Review 10.  Antacids. Indications and limitations.

Authors:  C K Ching; S K Lam
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.